MetaVia Investor Relations Material
Latest events
Investor Presentation
21 May, 2025
Q1 2025
14 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from MetaVia Inc
Access all reports
MetaVia Inc is a U.S.-based biotechnology company focused on developing treatments for metabolic and rare genetic diseases. The company is engaged in the research and clinical development of novel therapeutics targeting underlying disease mechanisms, with a goal of addressing unmet medical needs. MetaVia utilizes proprietary technology platforms and collaborates with research institutions to advance its pipeline. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for MetaVia Inc
Investor Presentation
MetaVia Inc
Investor Presentation
MetaVia Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
MTVA
Country
🇺🇸 United States